127 related articles for article (PubMed ID: 29377653)
1. Enzyme and Cancer Cell Selectivity of Nanoparticles: Inhibition of 3D Metastatic Phenotype and Experimental Melanoma by Zinc Oxide.
DeLong RK; Mitchell JA; Morris RT; Comer J; Hurst MN; Ghosh K; Wanekaya A; Mudge M; Schaeffer A; Washington LL; Risor-Marhanka A; Thomas S; Marroquin S; Lekey A; Smith JJ; Garrad R; Aryal S; Abdelhakiem M; Glaspell GP
J Biomed Nanotechnol; 2017 Feb; 13(2):221-31. PubMed ID: 29377653
[TBL] [Abstract][Full Text] [Related]
2. Comparative functional dynamics studies on the enzyme nano-bio interface.
Thomas SE; Comer J; Kim MJ; Marroquin S; Murthy V; Ramani M; Hopke TG; McCall J; Choi SO; DeLong RK
Int J Nanomedicine; 2018; 13():4523-4536. PubMed ID: 30127604
[TBL] [Abstract][Full Text] [Related]
3. Comparative Molecular Immunological Activity of Physiological Metal Oxide Nanoparticle and its Anticancer Peptide and RNA Complexes.
DeLong RK; Comer J; Mathew EN; Jaberi-Douraki M
Nanomaterials (Basel); 2019 Nov; 9(12):. PubMed ID: 31771091
[TBL] [Abstract][Full Text] [Related]
4. Three dimensional spheroid cell culture for nanoparticle safety testing.
Sambale F; Lavrentieva A; Stahl F; Blume C; Stiesch M; Kasper C; Bahnemann D; Scheper T
J Biotechnol; 2015 Jul; 205():120-9. PubMed ID: 25595712
[TBL] [Abstract][Full Text] [Related]
5. Zinc Oxide Nanoparticle-Poly I:C RNA Complexes: Implication as Therapeutics against Experimental Melanoma.
Ramani M; Mudge MC; Morris RT; Zhang Y; Warcholek SA; Hurst MN; Riviere JE; DeLong RK
Mol Pharm; 2017 Mar; 14(3):614-625. PubMed ID: 28135100
[TBL] [Abstract][Full Text] [Related]
6. Unique Boron Carbide Nanoparticle Nanobio Interface: Effects on Protein-RNA Interactions and 3-D Spheroid Metastatic Phenotype.
Delong RK; Hurst MN; Aryal S; Inchun NK
Anticancer Res; 2016 May; 36(5):2097-103. PubMed ID: 27127109
[TBL] [Abstract][Full Text] [Related]
7. Immobilization of Aspergillus oryzae β galactosidase on zinc oxide nanoparticles via simple adsorption mechanism.
Husain Q; Ansari SA; Alam F; Azam A
Int J Biol Macromol; 2011 Jul; 49(1):37-43. PubMed ID: 21439994
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Ras Binding Domain (RBD) by chemotherapeutic zinc oxide nanoparticles: Progress towards RAS pathway protein interference.
Mathew EN; Hurst MN; Wang B; Murthy V; Zhang Y; DeLong RK
PLoS One; 2020; 15(12):e0243802. PubMed ID: 33326476
[TBL] [Abstract][Full Text] [Related]
9. Biomimicry 3D gastrointestinal spheroid platform for the assessment of toxicity and inflammatory effects of zinc oxide nanoparticles.
Chia SL; Tay CY; Setyawati MI; Leong DT
Small; 2015 Feb; 11(6):702-12. PubMed ID: 25331163
[TBL] [Abstract][Full Text] [Related]
10. Zinc overload mediated by zinc oxide nanoparticles as innovative anti-tumor agent.
Wiesmann N; Kluenker M; Demuth P; Brenner W; Tremel W; Brieger J
J Trace Elem Med Biol; 2019 Jan; 51():226-234. PubMed ID: 30115501
[TBL] [Abstract][Full Text] [Related]
11. Comparing the effects of physiologically-based metal oxide nanoparticles on ribonucleic acid and RAS/RBD-targeted triplex and aptamer interactions.
Huslig G; Marchell N; Hoffman A; Park S; Choi SO; DeLong RK
Biochem Biophys Res Commun; 2019 Sep; 517(1):43-48. PubMed ID: 31307783
[TBL] [Abstract][Full Text] [Related]
12. Genotoxic effects of zinc oxide nanoparticles.
Heim J; Felder E; Tahir MN; Kaltbeitzel A; Heinrich UR; Brochhausen C; Mailänder V; Tremel W; Brieger J
Nanoscale; 2015 May; 7(19):8931-8. PubMed ID: 25916659
[TBL] [Abstract][Full Text] [Related]
13. Zinc oxide nanoparticles: Synthesis, antiseptic activity and toxicity mechanism.
Król A; Pomastowski P; Rafińska K; Railean-Plugaru V; Buszewski B
Adv Colloid Interface Sci; 2017 Nov; 249():37-52. PubMed ID: 28923702
[TBL] [Abstract][Full Text] [Related]
14. Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells.
Bai DP; Zhang XF; Zhang GL; Huang YF; Gurunathan S
Int J Nanomedicine; 2017; 12():6521-6535. PubMed ID: 28919752
[TBL] [Abstract][Full Text] [Related]
15. Can Be a Bimetal Oxide ZnO-MgO Nanoparticles Anticancer Drug Carrier and Deliver? Doxorubicin Adsorption/Release Study.
Kumar R; Gokulakrishnan N; Kumar R; Krishna VM; Saravanan A; Supriya S; Somanathan T
J Nanosci Nanotechnol; 2015 Feb; 15(2):1543-53. PubMed ID: 26353689
[TBL] [Abstract][Full Text] [Related]
16. Zinc Oxide Nanoparticles Suppress LPS-Induced NF-κB Activation by Inducing A20, a Negative Regulator of NF-κB, in RAW 264.7 Macrophages.
Kim MH; Jeong HJ
J Nanosci Nanotechnol; 2015 Sep; 15(9):6509-15. PubMed ID: 26716206
[TBL] [Abstract][Full Text] [Related]
17. Additive effect of zinc oxide nanoparticles and isoorientin on apoptosis in human hepatoma cell line.
Yuan L; Wang Y; Wang J; Xiao H; Liu X
Toxicol Lett; 2014 Mar; 225(2):294-304. PubMed ID: 24374571
[TBL] [Abstract][Full Text] [Related]
18. Differential Cytotoxicity Induced by Transition Metal Oxide Nanoparticles is a Function of Cell Killing and Suppression of Cell Proliferation.
Tolliver LM; Holl NJ; Hou FYS; Lee HJ; Cambre MH; Huang YW
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138333
[TBL] [Abstract][Full Text] [Related]
19. Zinc oxide nanoparticles induce lipoxygenase-mediated apoptosis and necrosis in human neuroblastoma SH-SY5Y cells.
Kim JH; Jeong MS; Kim DY; Her S; Wie MB
Neurochem Int; 2015 Nov; 90():204-14. PubMed ID: 26364578
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of zinc oxide nanoparticles usingMangifera indica leaves and evaluation of their antioxidant and cytotoxic properties in lung cancer (A549) cells.
Rajeshkumar S; Kumar SV; Ramaiah A; Agarwal H; Lakshmi T; Roopan SM
Enzyme Microb Technol; 2018 Oct; 117():91-95. PubMed ID: 30037558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
